GRDN logo

Guardian Pharmacy ServicesNYSE:GRDN Stock Report

Market Cap US$1.3b
Share Price
US$20.70
My Fair Value
AN
AnalystConsensusTarget
US$27
24.3% undervalued intrinsic discount
1Yn/a
7D-0.4%
Portfolio Value
View

Guardian Pharmacy Services, Inc.

NYSE:GRDN Stock Report

Market Cap: US$1.3b

Guardian Pharmacy Services (GRDN) Stock Overview

A pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. More details

GRDN fundamental analysis
Snowflake Score
Valuation2/6
Future Growth3/6
Past Performance0/6
Financial Health6/6
Dividends0/6

GRDN Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Guardian Pharmacy Services, Inc. Competitors

Price History & Performance

Summary of share price highs, lows and changes for Guardian Pharmacy Services
Historical stock prices
Current Share PriceUS$20.70
52 Week HighUS$26.91
52 Week LowUS$14.16
Beta0
1 Month Change1.87%
3 Month Change-14.07%
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO29.38%

Recent News & Updates

A Look At The Fair Value Of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Jun 25
A Look At The Fair Value Of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Recent updates

A Look At The Fair Value Of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Jun 25
A Look At The Fair Value Of Guardian Pharmacy Services, Inc. (NYSE:GRDN)

Guardian Pharmacy Services, Inc. Just Missed EPS By 17%: Here's What Analysts Think Will Happen Next

May 15
Guardian Pharmacy Services, Inc. Just Missed EPS By 17%: Here's What Analysts Think Will Happen Next

Guardian Pharmacy Services: Questions After A Successful IPO

Oct 02

Shareholder Returns

GRDNUS Consumer RetailingUS Market
7D-0.4%-0.08%1.3%
1Yn/a21.9%14.6%

Return vs Industry: Insufficient data to determine how GRDN performed against the US Consumer Retailing industry.

Return vs Market: Insufficient data to determine how GRDN performed against the US Market.

Price Volatility

Is GRDN's price volatile compared to industry and market?
GRDN volatility
GRDN Average Weekly Movement6.7%
Consumer Retailing Industry Average Movement5.3%
Market Average Movement6.3%
10% most volatile stocks in US Market17.2%
10% least volatile stocks in US Market3.1%

Stable Share Price: GRDN has not had significant price volatility in the past 3 months compared to the US market.

Volatility Over Time: GRDN's weekly volatility (7%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
20033,400Fred Burkeguardianpharmacy.com

Guardian Pharmacy Services, Inc., a pharmacy service company, provides a suite of technology-enabled services to help residents of long-term health care facilities (LTCFs) in the United States. Its individualized clinical, drug dispensing, and administration capabilities are used to serve the needs of residents in lower acuity LTCFs, such as assisted living facilities, behavioral health facilities, and group homes. The company’s Guardian Compass includes dashboards created using data from its data warehouse to help its local pharmacies plan, track, and optimize their business operations; GuardianShield Programs for LTCFs; Order Entry QA Analyzer, which utilizes real-time rules- engine technology to examine prescriptions and detect omissions and/or errors before they become a customer service problem; and Medication Spend Analyzer to break down the monthly drug spending for each of the LTCFs.

Guardian Pharmacy Services, Inc. Fundamentals Summary

How do Guardian Pharmacy Services's earnings and revenue compare to its market cap?
GRDN fundamental statistics
Market capUS$1.32b
Earnings (TTM)-US$100.60m
Revenue (TTM)US$1.28b
1.0x
P/S Ratio
-13.3x
P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GRDN income statement (TTM)
RevenueUS$1.28b
Cost of RevenueUS$1.03b
Gross ProfitUS$253.62m
Other ExpensesUS$354.22m
Earnings-US$100.60m

Last Reported Earnings

Mar 31, 2025

Next Earnings Date

Aug 11, 2025

Earnings per share (EPS)-1.55
Gross Margin19.78%
Net Profit Margin-7.85%
Debt/Equity Ratio0%

How did GRDN perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/07/23 21:31
End of Day Share Price 2025/07/23 00:00
Earnings2025/03/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Guardian Pharmacy Services, Inc. is covered by 5 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Kam Wai KwokCGS International
John RansomRaymond James & Associates
Scott FidelStephens, Inc.